Momelotinib: Mechanism of action, clinical, and translational science.

Vlasakakis G, McCabe MT, Ho YL, Ferron-Brady G, Martin P, Bentley D, Ellis C, Antonysamy M, Visser SAG

Open source

DOI
10.1111/cts.70018
Published
2024 Aug
Container
Clinical and translational science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.70018,
  title = {Momelotinib: Mechanism of action, clinical, and translational science.},
  author = {Vlasakakis G and McCabe MT and Ho YL and Ferron-Brady G and Martin P and Bentley D and Ellis C and Antonysamy M and Visser SAG},
  year = {2024},
  journal = {Clinical and translational science},
  doi = {10.1111/cts.70018},
  url = {https://doi.org/10.1111/cts.70018}
}

RIS

TY  - JOUR
TI  - Momelotinib: Mechanism of action, clinical, and translational science.
AU  - Vlasakakis G
AU  - McCabe MT
AU  - Ho YL
AU  - Ferron-Brady G
AU  - Martin P
AU  - Bentley D
AU  - Ellis C
AU  - Antonysamy M
AU  - Visser SAG
PY  - 2024
JO  - Clinical and translational science
DO  - 10.1111/cts.70018
UR  - https://doi.org/10.1111/cts.70018
ER  - 

APA

G, V., MT, M., YL, H., G, F., P, M., D, B., C, E., M, A., & SAG, V. (2024). Momelotinib: Mechanism of action, clinical, and translational science.. Clinical and translational science. https://doi.org/10.1111/cts.70018

Source records